Review

Oral drugs for type 2 diabetes, alone or in combination, have different relative benefits and harms for surrogate endpoints

Research output: Contribution to journalArticle

Original languageEnglish (US)
JournalAnnals of Internal Medicine
Volume155
Issue number4
StatePublished - Aug 16 2011

Fingerprint

Type 2 Diabetes Mellitus
Biomarkers
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Internal Medicine

Cite this

@article{d29e06b5fcec436c99087053842b5853,
title = "Review: Oral drugs for type 2 diabetes, alone or in combination, have different relative benefits and harms for surrogate endpoints",
author = "Wendy Bennett",
year = "2011",
month = "8",
day = "16",
language = "English (US)",
volume = "155",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "4",

}

TY - JOUR

T1 - Review

T2 - Oral drugs for type 2 diabetes, alone or in combination, have different relative benefits and harms for surrogate endpoints

AU - Bennett, Wendy

PY - 2011/8/16

Y1 - 2011/8/16

UR - http://www.scopus.com/inward/record.url?scp=80051636025&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051636025&partnerID=8YFLogxK

M3 - Article

VL - 155

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 4

ER -